Aiml Innovations Stock Fundamentals
AIMLF Stock | USD 0.05 0.01 18.30% |
AIML Innovations fundamentals help investors to digest information that contributes to AI/ML Innovations' financial success or failures. It also enables traders to predict the movement of AI/ML OTC Stock. The fundamental analysis module provides a way to measure AI/ML Innovations' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AI/ML Innovations otc stock.
AI/ML |
AIML Innovations OTC Stock Shares Outstanding Analysis
AI/ML Innovations' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AI/ML Innovations Shares Outstanding | 36.69 M |
Most of AI/ML Innovations' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AIML Innovations is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, AIML Innovations has 36.69 M of shares currently outstending. This is 79.68% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The shares outstanding for all United States stocks is 93.58% higher than that of the company.
AI/ML Innovations Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AI/ML Innovations's current stock value. Our valuation model uses many indicators to compare AI/ML Innovations value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AI/ML Innovations competition to find correlations between indicators driving AI/ML Innovations's intrinsic value. More Info.AIML Innovations is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AI/ML Innovations' earnings, one of the primary drivers of an investment's value.AI/ML Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AI/ML Innovations' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of AI/ML Innovations could also be used in its relative valuation, which is a method of valuing AI/ML Innovations by comparing valuation metrics of similar companies.AIML Innovations is currently under evaluation in shares outstanding category among its peers.
AI/ML Fundamentals
Return On Equity | -5.08 | |||
Return On Asset | -0.6 | |||
Operating Margin | (8.32) % | |||
Current Valuation | 2.1 M | |||
Shares Outstanding | 36.69 M | |||
Shares Owned By Insiders | 12.35 % | |||
Price To Earning | 0.31 X | |||
Price To Book | 5.30 X | |||
Price To Sales | 14.66 X | |||
Revenue | 65.41 K | |||
Gross Profit | 65.41 K | |||
EBITDA | (3.44 M) | |||
Net Income | (3.17 M) | |||
Cash And Equivalents | 294.31 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 40 K | |||
Debt To Equity | 1.82 % | |||
Current Ratio | 0.59 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | (3.02 M) | |||
Earnings Per Share | 0.13 X | |||
Beta | 1.06 | |||
Market Capitalization | 1.95 M | |||
Total Asset | 2.04 M | |||
Z Score | 25.5 | |||
Net Asset | 2.04 M |
About AI/ML Innovations Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AIML Innovations's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AI/ML Innovations using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AIML Innovations based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.AIML Innovations Inc. operates in the digital healthcare business using artificial intelligence and machine learning . AIML Innovations Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. AiMl Innovations is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in AI/ML OTC Stock
AI/ML Innovations financial ratios help investors to determine whether AI/ML OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AI/ML with respect to the benefits of owning AI/ML Innovations security.